News

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...
Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.
Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...
New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...
A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
In this second part of a three-part of a video series, Kasey Raetz, Pharm.D., a PBMI Innovator, told MHE about leading the ...
After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...
Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.
Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...
Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...
Patients with type 2 diabetes and atopic dermatitis show higher risk for cardiovascular events, but GLP-1 agonists reduce the ...